Use of non-homogeneous Poisson process for the analysis of new cases, deaths, and recoveries of COVID-19 patients: A case study of Kuwait

被引:0
|
作者
Al-Dousari, Ahmad [1 ]
Ellahi, Asad [2 ,3 ]
Hussain, Ijaz [3 ]
机构
[1] Kuwait Univ, Dept Geog, Kuwait, Kuwait
[2] Natl Univ Med Sci, Wah Med Coll, Dept Community Med, Rawalpindi, Pakistan
[3] Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan
关键词
Bayesian analysis; Non-homogeneous Poisson process; SARS-CoV-2; Markov chain; COVID-19; pandemic; Kuwait;
D O I
10.1016/jaksus.2021.101614
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The coronavirus disease spread out rapidly in China and then in the whole world. Kuwait is one of those countries which are positively affected by this pandemic. Objective: The current study aims to provide an appropriate and novel framework for the analysis of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infected patient & rsquo;s counts and rate of change in these counts with respect to time. Therefore, we considered the number of SARS-CoV-2 patients, i.e., confirmed cases, deaths, and recover-ies for Kuwait, ranging from the 24th of February 2020 to the 25th of August 2020. Method: Here, we used the Markov Chain Monte Carlo (MCMC) simulation methods for the data analysis of SARS-CoV-2 to develop the Bayesian analysis of the Non-Homogeneous Poisson Process (NHPP). For this purpose, we used the two unique models of NHPP: the linear intensity function and the power law process. The dis-crimination methods are also discussed to select a better model for daily basis data of confirmed cases, deaths, and recoveries of SARS-CoV-2 patients. The appropriate model is selected based on the Deviance Information Criteria (DIC). Results: The value of DIC indicates that the power-law process performs better than the linear intensity functions for estimating and presenting all the study variables. The current study explored the usefulness and significance of the proposed research framework to analyze the SARS-CoV-2 new confirmed cases, recoveries, and deaths in a specific area. Conclusion: The findings of the study will be helpful for the health organizations or authorities to develop the approaches based on the current resources and situations due to the pandemic. The provided framework could be beneficial in analyzing the second and third layers of COVID-19 in the area. The analysis of the counts for each study variable and for each variable a comparative analysis of all the three layers is the aim of our future study. (c) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 50 条
  • [41] A Case-Control Study of Prone Positioning in Awake and Non-Intubated Hospitalized COVID-19 Patients
    Nauka, P.
    Chekuri, S.
    Aboodi, M. S.
    Hope, A. A.
    Gong, M. N.
    Chen, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [42] Analysis and Evaluation of Non-Pharmaceutical Interventions on Prevention and Control of COVID-19: A Case Study of Wuhan City
    Cao, Wen
    Dai, Haoran
    Zhu, Jingwen
    Tian, Yuzhen
    Peng, Feilin
    ISPRS INTERNATIONAL JOURNAL OF GEO-INFORMATION, 2021, 10 (07)
  • [43] Statin Use in Hospitalized Patients with COVID-19: A Comprehensive Analysis of the New York City Public Hospital System
    Li, Weijia
    Rios, Saul
    Nagraj, Sanjana
    Hajra, Adrija
    Saralidze, Tinatin
    Varrias, Dimitrios
    Mathai, Sheetal Vasundara
    Novakovic, Marko
    Hupart, Kenneth H.
    Miles, Jeremy A.
    Katamreddy, Adarsh
    Palaiodimos, Leonidas
    Faillace, Robert T.
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 (07): : 897 - 905
  • [44] Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study
    Niccolò Buetti
    Alexis Tabah
    Ambre Loiodice
    Stéphane Ruckly
    Abdullah Tarik Aslan
    Giorgia Montrucchio
    Andrea Cortegiani
    Nese Saltoglu
    Bircan Kayaaslan
    Firdevs Aksoy
    Akova Murat
    Özlem Akdoğan
    Kemal Tolga Saracoglu
    Cem Erdogan
    Marc Leone
    Ricard Ferrer
    José-Artur Paiva
    Yoshiro Hayashi
    Mahesh Ramanan
    Andrew Conway Morris
    François Barbier
    Jean-François Timsit
    Critical Care, 26
  • [45] Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study
    Buetti, Niccolo
    Tabah, Alexis
    Loiodice, Ambre
    Ruckly, Stephane
    Aslan, Abdullah Tarik
    Montrucchio, Giorgia
    Cortegiani, Andrea
    Saltoglu, Nese
    Kayaaslan, Bircan
    Aksoy, Firdevs
    Murat, Akova
    Akdogan, Ozlem
    Saracoglu, Kemal Tolga
    Erdogan, Cem
    Leone, Marc
    Ferrer, Ricard
    Paiva, Jose-Artur
    Hayashi, Yoshiro
    Ramanan, Mahesh
    Morris, Andrew Conway
    Barbier, Francois
    Timsit, Jean-Francois
    CRITICAL CARE, 2022, 26 (01)
  • [46] Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19 A Case-Control Study in New York City
    Thakur, Kiran T.
    Chu, Victoria T.
    Hughes, Christine
    Kim, Carla Y.
    Fleck-Derderian, Shannon
    Barrett, Catherine E.
    Matthews, Elizabeth
    Balbi, Alanna
    Bilski, Amanda
    Chomba, Mashina
    Lieberman, Ori
    Jacobson, Samuel D.
    Agarwal, Sachin
    Roh, David
    Park, Soojin
    Ssonko, Vivian
    Silver, Wendy G.
    Vargas, Wendy D.
    Geneslaw, Andrew
    Bell, Michelle
    Waters, Brandon
    Rao, Agam
    Claassen, Jan
    Boehme, Amelia
    Willey, Joshua Z.
    Elkind, Mitchell S., V
    Sobieszczyk, Magdalena E.
    Zucker, Jason
    McCollum, Andrea
    Sejvar, James
    NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (04) : E66 - E74
  • [47] Convalescent plasma therapy in COVID-19 patients: a non-randomized case-control study with concurrent control
    Cacilhas, P.
    Caberlon, E.
    Angoleri, L.
    Fassina, K.
    Ribeiro, R. N.
    Pinto, L. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2022, 55 (01)
  • [48] Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis
    Weijun Jiang
    Weiwei Li
    Qiuyue Wu
    Ying Han
    Jing Zhang
    Tao Luo
    Yanju Guo
    Yang Yang
    Peiran Zhu
    Xinyi Xia
    Infectious Diseases and Therapy, 2021, 10 : 1677 - 1698
  • [49] Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis
    Jiang, Weijun
    Li, Weiwei
    Wu, Qiuyue
    Han, Ying
    Zhang, Jing
    Luo, Tao
    Guo, Yanju
    Yang, Yang
    Zhu, Peiran
    Xia, Xinyi
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (03) : 1677 - 1698
  • [50] A new standard scoring for interstitial pneumonia based on quantitative analysis of ultrasonographic data: A study on COVID-19 patients
    Lombardi, Fiorella Anna
    Franchini, Roberto
    Morello, Rocco
    Casciaro, Ernesto
    Ianniello, Stefania
    Serra, Maurizio
    Satriano, Francesco
    Mojoli, Francesco
    Mongodi, Silvia
    Pignatelli, Daniela
    Di Paola, Marco
    Casciaro, Sergio
    RESPIRATORY MEDICINE, 2021, 189